great potential for the treatment of several seasonal, chronic and emerging RNA virus 23 infections of humans, suggesting applicability to control some viral outbreaks. 
112
To examine whether the decrease in progeny production was associated with increased 
149
These results indicate that favipiravir is a mutagenic agent for RVFV and suggest
150
that its anti-RVFV activity may be exerted at least in part through lethal mutagenesis.
151

DISCUSSION
152
The broad spectrum antiviral activity of favipiravir has been established with The origin and passage history of the viral populations analysed is described in Fig. 2 and Materials and Methods.
497
b The genomic region analysed spans residues 2110-3199 of glycoprotein Gc coding region; the residue numbering is that of the SA-75 genome.
498
The values in parenthesis indicate the number of clones analysed followed by the number of haplotypes (number of different RNA sequences).
The number of different and total mutations were counted relative to the consensus sequence of the corresponding population. Different and 500 total mutations were used to calculate the minimum and maximum mutation frequency, respectively. 
